The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer
Authors:
- Michael StotzMSMichael Stotz
- Gerald HoeflerGerald Hoefler
- Armin GergerAGArmin Gerger
- Martin PichlerMPMartin Pichler
- 1 January 2015
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 53 (3) , 499-506
Abstract
Background: Intra-tumoral macrophages have been involved as important players in the pathogenesis and progression of cancer. Recently, inflammatory parameters of the systemic inflammatory response have also been proposed as usefully prognostic biomarkers. One of these, the lymphocyte to monocyte ratio (LMR) in peripheral blood has been shown as a prognostic factor in hematologic and some solid tumors. In this study we analyzed for the first time the prognostic value of LMR in a large middle European cohort of pancreatic cancer (PC) patients. Methods: Data from 474 consecutive patients with ductal adenocarcinoma of the pancreas were evaluated retrospectively. Cancer-specific survival (CSS) was analyzed using the Kaplan-Meier method. To further evaluate the prognostic significance of the LMR, univariate and multivariate Cox regression models were calculated. Results: Increased LMR at diagnosis was significantly associated with well-established prognostic factors, including high tumor stage and tumor grade (pConclusions: In conclusion, we identified LMR as an independent prognostic factor in PC patients. Our results indicate that the LMR might represent a novel and useful marker for patient stratification in PC management.Keywords
This publication has 20 references indexed in Scilit:
- Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminaseOncogene, 2013
- Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: A quid pro quo in pancreatic cancerPancreatology, 2013
- Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancerAnnals of Oncology, 2013
- Tumour‐associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinomaHistopathology, 2013
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaHaematologica, 2011
- Trophic macrophages in development and diseaseNature Reviews Immunology, 2009
- Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast CancerCancer Research, 2006
- Reporting Recommendations for Tumor Marker Prognostic StudiesJournal of Clinical Oncology, 2005
- Standards for Reporting Prognostic Tumor Marker StudiesJournal of Clinical Oncology, 2005